Nevro EBITDA Margin 2013-2024 | NVRO

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Nevro (NVRO) over the last 10 years. The current EBITDA margin for Nevro as of September 30, 2024 is .
Nevro EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2024-09-30 $0.42B $-0.07B -17.66%
2024-06-30 $0.43B $-0.09B -20.19%
2024-03-31 $0.43B $-0.09B -20.19%
2023-12-31 $0.43B $-0.09B -20.94%
2023-09-30 $0.42B $-0.10B -22.93%
2023-06-30 $0.42B $0.01B 2.63%
2023-03-31 $0.41B $0.01B 3.14%
2022-12-31 $0.41B $0.02B 4.19%
2022-09-30 $0.40B $0.01B 3.29%
2022-06-30 $0.39B $-0.11B -29.38%
2022-03-31 $0.39B $-0.10B -26.68%
2021-12-31 $0.39B $-0.09B -23.00%
2021-09-30 $0.39B $-0.06B -15.74%
2021-06-30 $0.41B $-0.02B -4.16%
2021-03-31 $0.36B $-0.03B -9.37%
2020-12-31 $0.36B $-0.04B -10.80%
2020-09-30 $0.37B $-0.05B -12.88%
2020-06-30 $0.36B $-0.07B -18.21%
2020-03-31 $0.40B $-0.06B -15.95%
2019-12-31 $0.39B $-0.08B -21.28%
2019-09-30 $0.38B $-0.09B -23.18%
2019-06-30 $0.38B $-0.08B -21.58%
2019-03-31 $0.38B $-0.06B -16.75%
2018-12-31 $0.39B $-0.04B -9.79%
2018-09-30 $0.38B $-0.03B -8.20%
2018-06-30 $0.36B $-0.03B -7.42%
2018-03-31 $0.35B $-0.03B -8.38%
2017-12-31 $0.33B $-0.03B -8.28%
2017-09-30 $0.30B $-0.03B -10.70%
2017-06-30 $0.28B $-0.03B -10.43%
2017-03-31 $0.26B $-0.03B -10.20%
2016-12-31 $0.23B $-0.02B -9.61%
2016-09-30 $0.19B $-0.03B -15.18%
2016-06-30 $0.15B $-0.05B -31.72%
2016-03-31 $0.10B $-0.06B -58.42%
2015-12-31 $0.07B $-0.06B -89.86%
2015-09-30 $0.05B $-0.06B -121.74%
2015-06-30 $0.04B $-0.04B -110.00%
2015-03-31 $0.04B $-0.03B -86.49%
2014-12-31 $0.03B $-0.03B -79.41%
2014-06-30 $0.02B $-0.02B -90.48%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.153B $0.425B
Nevro Corp. is a medical device company which engages in developing and commercializing a neuromodulation platform for the treatment of chronic pain, primarily in the leg. The company is known for developing and commercializing the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. Additionally, the company's HF10 therapy provides long-lasting relief from chronic back and leg pain. Nevro's flagship Senza SCS system has been consistently driving the top line. Since its commercial launch in the United States, the system raked in significant revenues. These apart, Senza is commercially available in Europe since 2010 and in Australia since 2011.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $201.535B 24.59
Intuitive Surgical (ISRG) United States $192.187B 100.48
Edwards Lifesciences (EW) United States $43.244B 27.46
Alcon (ALC) Switzerland $41.516B 27.78
IQVIA Holdings (IQV) United States $36.129B 19.91
IDEXX Laboratories (IDXX) United States $35.383B 41.67
DexCom (DXCM) United States $30.150B 45.41
Waters (WAT) United States $22.460B 33.21
STERIS (STE) Ireland $21.145B 24.34
SONOVA HOLDING (SONVY) Switzerland $19.656B 0.00
Hologic (HOLX) United States $16.714B 18.05
Fresenius Medical Care AG KGaA (FMS) Germany $13.878B 14.25
Sysmex ADR (SSMXY) Japan $11.893B 37.30
Globus Medical (GMED) United States $11.223B 28.42
Masimo (MASI) United States $9.431B 45.63
Penumbra (PEN) United States $9.424B 92.31
Teleflex (TFX) United States $8.366B 13.34
Glaukos (GKOS) United States $7.660B 0.00
PROCEPT BioRobotics (PRCT) United States $4.657B 0.00
Integer Holdings (ITGR) United States $4.653B 26.37
Veracyte (VCYT) United States $3.350B 100.51
Inari Medical (NARI) United States $3.254B 0.00
LivaNova (LIVN) United Kingdom $2.797B 16.14
Nihon Kohden (NHNKY) Japan $2.380B 18.08
Elekta AB (EKTAY) Sweden $2.206B 19.83
TransMedics (TMDX) United States $2.157B 68.36
Tandem Diabetes Care (TNDM) United States $2.145B 0.00
Integra LifeSciences Holdings (IART) United States $1.854B 9.69
RxSight (RXST) United States $1.503B 0.00
Alphatec Holdings (ATEC) United States $1.364B 0.00
Artivion (AORT) United States $1.213B 80.36
Pulse Biosciences (PLSE) United States $1.086B 0.00
OPKO Health (OPK) United States $1.085B 0.00
Paragon 28 (FNA) United States $0.872B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.826B 14.04
Mesa Laboratories (MLAB) United States $0.693B 16.33
ORTHOFIX MEDICAL INC (OFIX) United States $0.686B 0.00
IRadimed (IRMD) United States $0.667B 36.05
AxoGen (AXGN) United States $0.623B 0.00
SiBone (SIBN) United States $0.563B 0.00
Semler Scientific (SMLR) United States $0.557B 32.77
Pacific Biosciences Of California (PACB) United States $0.537B 0.00
OrthoPediatrics (KIDS) United States $0.536B 0.00
Treace Medical Concepts (TMCI) United States $0.467B 0.00
Tactile Systems Technology (TCMD) United States $0.430B 23.27
ClearPoint Neuro (CLPT) United States $0.423B 0.00
Delcath Systems (DCTH) United States $0.387B 0.00
AngioDynamics (ANGO) United States $0.366B 0.00
NeuroPace (NPCE) United States $0.329B 0.00
CVRx (CVRX) United States $0.311B 0.00
Alpha Tau Medical (DRTS) Israel $0.215B 0.00
Inogen (INGN) United States $0.213B 0.00
KORU Medical Systems (KRMD) United States $0.197B 0.00
Accuray (ARAY) United States $0.193B 0.00
Sight Sciences (SGHT) United States $0.182B 0.00
Atossa Genetics (ATOS) United States $0.141B 0.00
Sensus Healthcare (SRTS) United States $0.134B 14.32
Spectral Diagnostics (EDTXF) Canada $0.099B 0.00
Monogram Orthopaedics (MGRM) United States $0.091B 0.00
LENSAR (LNSR) United States $0.088B 0.00
Vicarious Surgical (RBOT) United States $0.084B 0.00
EDAP TMS S.A (EDAP) France $0.082B 0.00
WORK Medical Technology Group (WOK) China $0.079B 0.00
InspireMD (NSPR) Israel $0.077B 0.00
Hyperfine (HYPR) United States $0.073B 0.00
908 Devices (MASS) United States $0.072B 0.00
Covalon Technologies (CVALF) Canada $0.064B 0.00
EnVVeno Medical (NVNO) United States $0.050B 0.00
Lucid Diagnostics (LUCD) United States $0.047B 0.00
Rapid Micro Biosystems (RPID) United States $0.043B 0.00
Envoy Medical (COCH) United States $0.040B 0.00
Neuronetics (STIM) United States $0.034B 0.00
Spectral AI (MDAI) United States $0.033B 0.00
Accelerate Diagnostics (AXDX) United States $0.033B 0.00
Precision Optics (POCI) United States $0.032B 0.00
NexGel (NXGL) United States $0.032B 0.00
Adagio Medical Holdings (ADGM) United States $0.029B 0.00
Biosig Technologies (BSGM) United States $0.025B 0.00
DarioHealth (DRIO) United States $0.025B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.015B 0.00
Aspira Women's Health (AWH) United States $0.013B 0.00
Ekso Bionics Holdings (EKSO) United States $0.012B 0.00
QT Imaging Holdings (QTI) United States $0.011B 0.00
Baird Medical Investment Holdings (BDMD) $0.010B 0.00
PAVmed (PAVM) United States $0.008B 0.00
T2 Biosystems (TTOO) United States $0.008B 0.00
Tenon Medical (TNON) United States $0.006B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.004B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
Check-Cap (CHEK) Israel $0.004B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
Bluejay Diagnostics (BJDX) United States $0.003B 0.00
Venus Concept (VERO) Canada $0.003B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
ENDRA Life Sciences (NDRA) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00